Nonetheless, opposite results have been also described, in which osteopontin-derived autophagy promoted chemoresistance in HCC cell lines [44], and autophagy targeting enhanced the antitumor actions of sorafenib [45]. This evidence concerns the gene SPP1 and hepatocellular carcinoma.